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Objectives: The examination of the effects of stress in university students dur-
ing the exam period, compared with demographic data. MethOds: Prospective 
research was made in the exam period. Altogether 181 university students par-
ticipated in the study, in the course of which online questionnaire were applied. 
In the first part of the questionnaire demographic questions were listed, while 
Student Nursing Stress Index (SNSI) questionnaire was applied to measure stress 
level. Emotions perceived in a given moment could be evaluated by the Brunel Mood 
Scale. In the last part of the questionnaire Marlowe- Crowne Senior Short Form 
Social Desirability Scale (MCSDS) was applied to evaluate behaviour desired by the 
society. The analysis of results was performed with SPSS 20.00 and MO Excel 2007 
programs. For data analysis descriptive statistics, χ 2-test, t-test, variance analy-
sis and regression analysis besides the significance level p< 0,05. Results: The 
division of genders was 28 (15,47%) male and 153 (84,53%) female participants in 
the research (n= 181). The average age was 21,62±3,07 years. The measurement of 
stress showed that sleeping time of students can be significantly affected by stress 
(p< 0,001). Those whose parents are divorced reached higher points in the value of 
stress (p= 0,038). Stress load caused by the exams did not show significant difference 
between specialities (p> 0,05). In the course of the research we found that senior 
students experienced significantly more stress in the exam period than freshmen 
(p= 0,013). cOnclusiOns: As the result of the measurements it can be said that 
stress is continuously present in students. Besides the requirements of the univer-
sity students have to cope with several other problems.
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Objectives: Medication non-adherence is often classified by the timing of non-
adherence. Primary non-adherence is the failure to fill a newly-prescribed medica-
tion (Rx). Rx non-persistence is the failure to continue therapy after the initial fill. A 
recent classification − early non-persistence (ENP) − is the failure to obtain the first 
prescribed refill of a new Rx (single dispensation only). In this meta-analytic review, 
we compare the rates of ENP across studies by four moderator dimensions: (1) chronic 
disease class; (2) symptomatic vs. asymptomatic chronic condition; (3) length of the 
baseline treatment-free interval; and (4) whether ENP estimates were adjusted for 
Rx switches. MethOds: Fifty-eight studies that contained data on ENP were identi-
fied using a PubMed literature search and searches of each article’s reference list. 
ENP rates were recorded for 91 distinct samples. ENP was defined as the failure to 
obtain the first prescribed refill within 30 days of the first-refill date. ENP rates were 
weighted by sample size and combined to provide pooled fixed effect size estimates 
for the moderator dimensions. Results: Across all samples, the overall weighted ENP 
rate was 23.6%. Observed difference between ENP rates by disease class were largely 
explained by whether the treatment focused on symptom control or not: symptomatic 
ENP rate= 39.5% vs. asymptomatic ENP rate= 17.7%. ENP rates were affected by two 
aspects of methodology: (1) length of baseline treatment-free interval (shorter, favor-
ing treatment-experienced= 17.1% vs. longer, favoring treatment-naïve= 27.2%); and (2) 
Rx switches accounted for in the ENP estimates (accounting for switch= 18.8% vs. not 
accounting for switch= 26.0%). cOnclusiOns: ENP is as high, and can be higher than 
primary non-adherence. Most extant studies simply document the rate of ENP. Given 
that ~ 24% of patients are “one-and-done,” it is imperative to: (1) understand the driv-
ers of ENP and (2) develop patient-centered interventions to stem the epidemic of ENP.
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PatIentS’ accePtance oF tHeIr MedIcatIon: reSuLtS FroM a FrencH 
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tHe accePtance by tHe PatIentS oF tHeIr treatMent (accePt©) 
QueStIonnaIre
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Objectives: Lack of adherence and persistence can be major barriers to treatment 
efficiency in real world, for many chronic diseases. Measuring patients’ acceptance 
of their medication is thus gaining importance as it is likely to help better under-
stand and predict patients’ behavior towards treatment. The generic ACCEptance 
by the Patients of their Treatment (ACCEPT) questionnaire was developed to meas-
ure patients’ acceptance of their medication. The objective of this study was to 
evaluate for a variety of diseases the level of acceptance in real life using a patient 
online community. MethOds: This study was observational, cross-sectional, con-
ducted through the French Carenity platform. All patients connected were invited 
to complete an online questionnaire including demographics, chronic disease and 
treatment, and the 25 ACCEPT items. ACCEPT includes 6 multi-item acceptance 
dimensions (Medication Inconvenience, Long-term Treatment, Regimen Constraints, 
Side Effects, Effectiveness and General; range 0-100; higher score= greater accept-
ance) and one single-item acceptance dimension (Numerous Medications; range 
1-3). Patients included in the analysis were suffering from any chronic diseases 
with at least 50 respondents and currently receiving a treatment for this dis-
ease. Results: Responding patients had breast cancer (n= 57), type 1 diabetes 
(n= 101), type 2 diabetes (n= 213), fibromyalgia (n= 135), rheumatoid arthritis (n= 98), 
multiple sclerosis (n= 260), ankylosing spondylitis (n= 134) or bipolar disorder (n= 65). 
Most respondents were female (49% to 100%), with mean age 44 to 61. Mean (SD) 
ACCEPT General score was: 36 (33) for breast cancer, 64 (31) for type 1 diabetes, 54 
(32) for type 2 diabetes, 35 (31) for fibromyalgia, 39 (31) for rheumatoid arthritis, 50 
population consisted of older people (≥ 65 years) with polypharmacy (≥ 5 drugs) and 
the study was conducted in 178 community pharmacies in Spain. A total of 1,403 
patients were enrolled, 688 in the intervention group (IG) and 715 in the control 
group (CG). The analysis adopted the perspective of the National Health Service 
(NHS). In order to analyze the uncertainty of ICER results, we performed a non-
parametric bootstrapping with 5,000 replications. Results: Both groups reduced 
the average number of prescribed medications, although this reduction was greater 
in the IG (0.28 drugs; p< 0.001) than in the CG (0.07 drugs; p= 0.063). Patients in the 
IG showed an improvement in their quality of life by 0.0528 in the utility score 
(p< 0.001). By contrast, patients in the CG showed no differences in their quality of 
life by 0.0022 in the utility score (p= 0.815). We obtained an ICER of € 8,542/QALY and 
€ 6,777/QALY for the first and second scenario respectively, and a MRF as dominant 
strategy for the third, fourth and fifth scenario. For a willingness to pay of € 30,000/
QALY, the probability of the MRF being cost-effective, compared to usual dispensing, 
is in a range between 98.2% and 100% for the five scenarios. cOnclusiOns: MRF is 
an effective intervention for optimizing prescribed medication and improving the 
quality of life of older people with polypharmacy in community pharmacies. The 
results from the cost-utility analysis suggest that MRF is cost-effective.
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Objectives: To evaluate health care resource utilization and costs of patients 
diagnosed with Alzheimer’s disease (AD) and residing in long-term care facili-
ties. MethOds: A retrospective database analysis was performed using the 
Minimum Data set (MDS) linked to 5% Medicare data from 01JAN2008 through 
31DEC2011. AD patients were identified using International Classification of Disease, 
9thRevision, Clinical Modification (ICD-9-CM) diagnosis code 331.0. The first diag-
nosis date was designated as the index date. A comparison cohort was created for 
patients without an AD diagnosis, using 1: 1 propensity score matching (PSM) to con-
trol for baseline characteristics (age, region, gender, index year, baseline Charlson 
Comorbidity Index [CCI] score). For the comparison cohort, the index date was 
randomly chosen to reduce selection bias. Patients in both cohorts were required 
to be age ≥ 65 years, with at least two consecutive quarterly assessments in MDS 
data in the 6 months pre-index date and 1-year continuous medical and pharmacy 
benefits enrollment pre- and post-index date. Study outcomes (health care costs and 
utilizations) were compared between the cohorts. Results: After 1: 1 matching, a 
total of 2,158 patients were identified for the disease and comparison cohorts, and 
baseline characteristics were balanced. The AD cohort had a higher percentage of 
inpatient stays (33.73% vs. 24.93%, p< 0.0001), outpatient visits (92.22% vs. 89.99%, 
p= 0.01) and skilled nursing facility (SNF) (32.53% vs. 28.41%, p< 0.01) and hospice 
admissions (11.03% vs. 7.14%, p< 0.0001) than the comparison cohort. The AD cohort 
also incurred higher inpatient ($5,442 vs. $4,001, p< 0.001), SNF ($5,679 vs. $4,523, 
p< 0.01) and hospice stay costs ($3,164 vs. $2,047, p< 0.001) as well as carrier claim 
($2,907 vs. $2,686, p= 0.03) and pharmacy costs ($5,043 vs. $4,722, p= 0.01), compared 
to the comparison cohort. cOnclusiOns: AD was associated with higher health 
care resource utilization and a significantly higher economic burden.
IndIVIduaL’S HeaLtH – Patient-reported outcomes & Patient  
Preference Studies
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InStruMent For IdentIFyIng PotentIaL rISk FactorS aSSocIated  
WItH MedIcatIon-reLated non-adHerence
Müller S., Wilke T.
IPAM, University Wismar, Wismar, Germany
Objectives: Medication-related non-adherence is a major challenge in the real-
life treatment of patients. To meet this challenge successfully, adherence inter-
ventions with a tailored approach towards patient-specific adherence barriers are 
needed. Therefore, a reliable and practicable questionnaire for identification of those 
adherence barriers in specific patients is needed. The aim of this investigation is 
to develop and validate such a questionnaire. MethOds: The “Adherence Barriers 
Questionnaire (ABQ)” was developed and tested in 432 patients with atrial fibrilla-
tion in a multicenter observational cohort study. Evaluation of the questionnaire 
included an assessment of internal consistency as well as factor analysis. Criterion-
related external validity was appraised by comparing the ABQ score with the score of 
a self-report adherence measure and with a clinical parameter (time in therapeutic 
range (TTR) regarding INR values in the VKA-based stroke prophylaxis treatment 
of patients). Results: The final 14-item ABQ scale demonstrated high internal 
consistency (Cronbach’s alpha= 0.820). Factor analysis identified a three-factor solu-
tion, representing intentional adherence barriers with 5 items (31.9% of the vari-
ance), medication- or health care system-related adherence barriers with 5 items 
(13.3% of the variance) and unintentional adherence barriers with 4 items (7.7% of 
the variance). The ABQ correlated significantly with self-reported non-adherence 
(Spearman’s rho= 0.438, P< 0.001) as well as TTR (Spearman’s rho= -0.161, P< 0.01). 
Patients with above-average ABQ scores (increased number of existing adherence 
barriers) were significantly (p< 0.005, Pearson Chi-Square) more likely to have a poor 
anticoagulation quality (TTR< 60%) than patients with a lower ABQ score (44.6% 
versus 27.3%). cOnclusiOns: The ABQ is a practicable, reliable and valid instrument 
for identifying specific barriers to medication-related adherence. Future research is 
required to examine the ability of the ABQ to identify patient perception/behavior 
changes over time which may be important for the measurement of success of adher-
ence interventions.
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report well. However, the utilities subsequently derived followed an unconventional, 
bunched shape compared to the original study. By optimizing the parameters in 
order to minimize the sum of squared errors between approaches, a more suitable 
approach (“Beta rank fit”) was identified. Utilities could in principle therefore be 
derived using this method alone, without recourse to TTO models. cOnclusiOns: 
This paper outlines an approach that may be suitable for converting ordinal prefer-
ence data into cardinal utilities, and offering a number of advantages over previously 
described approaches. Ranking exercises for participants are considerably easier to 
carry out than full TTO studies, so the approach may be suitable for resource limited 
settings or for underrepresented subpopulations.
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Objectives: Pressure Ulcers are an important health care problem, recognized as 
‘Never Events’ by the US Government. To date, there is no instrument to capture 
their health utility impact, or the value of treatments and prevention strategies. The 
Pressure Ulcer Quality of Life Utility Instrument (PUQol-UI) is a condition specific 
preference-based measure designed to capture the impact of having a pressure 
ulcer (PU) on an individual’s health related quality of life and will allow calcula-
tion of QALYs necessary for cost-effectiveness analyses. PUQol-UI consists of 7 
domains (Pain, Mobility, Activities of Daily Living, Energy, Depression, Burden and 
Social Function). Each domain has three possible response levels: ‘No Bother’, ‘Little 
Bother’, and ‘A lot of Bother’. MethOds: A valuation exercise obtained Time Trade-
Off values for 51 PUQol-UI health states in 200 interviews with the UK General 
Population. OLS, Random Effects and Fixed Effects linear regression models were 
fitted and evaluated using tests of standard goodness of fit and estimation and vali-
dation sample predictive performance. Results: The Random Effects model was 
superior in fit and predictive performance, with 83% of states predicted to within 
0.1 of the observed mean. Preliminary analysis of the psychometric properties of 
the PUQoL-UI indicates adequate levels of validity and may offer measurement 
advantages over the generic EQ-5D measure. cOnclusiOns: The PUQol-UI is a 
useful addition to the portfolio of condition specific utility measures available to 
researchers interested in economic evaluation of technologies for the management 
of pressure ulcers, and health care decision makers responsible for funding such 
technologies.
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Objectives: Impaired Health-Related Quality of Life (HRQoL) of women due to vari-
ous symptoms of menopause impairments has been given increased importance 
in the past years. The objective of the present study is to estimate utility values for 
symptoms relevant for menopause-specific disturbances and to convert them into 
women’s willingness to give away months of life (time-trade-off) for relief of those 
symptoms. MethOds: A time-trade-off (TTO) model was applied to estimate the 
utilities of 7 symptoms caused by menopause impairments. A German version of 
the QualiPause Inventory (QPI) was used for assessing the severity of the symptoms. 
A quota sample of 478 women, aged 45 to 60 years, was interviewed. Health states 
were presented to participating women on a mobile computer screen, and they 
were asked to specify the willingness to give away months/years for the relief of 
the symptoms, using time-scaled graphic slide controls visible on the computer 
screen. A total of 45 health states were valued out of a potential of 2,187 defined 
by the classification system. Logistic regression and Bayes methods were used to 
estimate the utility values. Utility values were converted into trade-off willingness 
for life months. Both methods led to almost identical results. Results: Willingness 
to trade-off life months for relief of symptoms ranges between Zero and 132 months 
of life with a median of 12 months. 25% of the women were willing to trade-off 
more than 45 months, 5% more than 100 months and 1% even 132 months or more. 
Among the more severely rated symptoms are dryness of the vagina, bleedings, 
and anxiety. cOnclusiOns: Time-Trade-Off techniques can be used to estimate 
preference values for health states affected by menopausal symptoms and their 
relief. These values can be used to estimate differential outcomes of hormone 
replacement therapy.
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Objectives: To determine whether and how the location influences the way peo-
ple perceive their health in the US using BRFSS data 2012. The explained variable, 
general health, has five modalities (excellent (1), very good (2), good (3), fair (4) and 
poor (5)). MethOds: Using BRFSS data 2012, a descriptive study and chi-square 
test have been conducted crossing the general health variable with the location 
variable. This variable has been combined in ten modalities (New England, Mid-
Atlantic, East North Central, West North Central, South Atlantic, East South Central, 
West South Central, Mountain, Pacific and Guam/Puerto Rico). It has been followed 
by an ordered logit model to explain general health variable by the location using 
stepwise selection. Results: The study has been carried on 474,124 weighted indi-
viduals from BFRSS data 2012. The chi-square value is 962,244 and the p-value was 
lower than 0.001. Some regions such as Pacific, mid Atlantic, mountain and new 
England were found in a higher proportion among the excellent and very good 
health groups than in all the population (P: 11.7% and 10.6% vs 10.5%; MI: 11.9%, 
(31) for multiple sclerosis, 34 (33) for ankylosing spondylitis and 45 (33) for bipolar 
disorder. cOnclusiOns: This study enabled ACCEPT data to be collected in real 
life for a variety of chronic diseases. These data can be of major interest to help 
evaluating and interpreting level of acceptance in future studies.
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Objectives: The aim of our study was to explore the efficiency of “FÜGE” school-drug 
prevention program based on the students attitude change. MethOds: The research 
program was made at the Zipernowsky Károly Secondary Technical School with a 
standard questioner. Pre-test was made 10 days before and post-test 10 days after the 
school-drug prevention program. 94 people participated in the research. We processed 
our data with the help of MS excel 2007 and we prepared a T-test with it. Results: 
The results showed that the rate of those, who know everything about drugs have 
grown from 52,1% to 59,6% and those, who did not know anything decreased from 
3,2% to 2,1% (p= 0,181) before and after the drug-prevention program. The effect of 
the “FÜGE” program also changed the student’s sense of danger regarding drugs sig-
nificantly. There was a significant change (p= 0,008) in the trying of marihuana and 
hashish. Based on the given answer’s T-tests there were also significant differences in 
the test of hallucinogenic drugs (p= 0,012) and amphetamine, speed (p= 0,046). There 
was an almost significant (p= 0,071) correlation regarding the occasional usage of 
amphetamine, speed. Furthermore, after the program was made, significantly more 
students believes that trying (p= 0,001), using occasionally (p= 0,050) and using regu-
larly (p= 0,003) herbal drugs is dangerous. However, less than 7% percent of the stu-
dents agreed the statements: “I have learned a lot from the occasions.” and “I received 
answers for a lot of question that I was interested in earlier.” cOnclusiOns: “FÜGE” 
program is considered successful, because the participants’ knowledge increased, 
their sense of danger changed, but only half of them had a positive opinion about the 
program’s information-amount. We have to state that the changes in the knowledge 
about drug usage not necessarily lead to changes in behavior.
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PatIent PerSPectIVe: Pro coMPLIance and eFFectIVe reMInder 
StrategIeS
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Objectives: Survey data results providing patient perspectives on compliance and 
reminder-use in studies including Patient Report Outcomes (PROs) is shared. This 
presentation looks at patients’ preferred reminder modes, identifies what may impact 
diary compliance, and evaluates reminder strategies. MethOds: The survey was 
conducted in 2013, including patients globally (N= 405) who participated in at least one 
clinical trial in the past two years with patient diaries. Patients were asked about their 
most recent diary experience (including compliance), future trial participation (includ-
ing preferences for receiving reminders-content/modality/timing), and personal tech-
nology behaviors. Results: Only 53.6% of patients reported always being compliant 
with completing diary entries. Factors associated with non-compliance were age, 
dissatisfaction, and hard to remember diaries. Reasons for non-compliance included: 
“They Forgot” (51.4%), “Too Busy” (41.1%), “Access” (27.6%), and “Other” (2.7%). Patients 
(77.2%) provided high attractiveness ratings for reminders in future trials. Preferred 
reminder modes include: text messages (67.2%), hand-held alerts (34.3%), phone calls 
(34.1%), calendar alerts (32.6%), and email (6.2%). The majority of patients want to 
receive reminders for: diaries (97.3%), appointments (95.8%), and medication (95.0%). 
Most patients indicated checking text messages and emails daily. Significantly more 
patients check text messages immediately compared to email suggesting that text 
messages may be more effective for reminding patients. Majority reported owning 
some mode of technology; therefore, reminder strategies should be tailored to patient 
mode availability. cOnclusiOns: As self-reported by patients, forgetting is the top 
reason for non-compliance which can be highly prevalent in trials. Results show 
patients feel reminders are helpful. Patients would like to be reminded of various 
events. Reminder strategies should account for patient preferences and mode avail-
ability to keep patient satisfaction high. Effective reminder strategies can positively 
affect compliance, satisfaction and patient experiences in clinical trials. Reminder 
practices can also be rolled out to benefit compliance in health care.
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Objectives: EQ-5D is a standardised instrument for use as a measure of health 
outcome. There are well-documented problems regarding how best to measure 
worse than dead states using the Time Trade Off (TTO) approach. We attempted to 
generate utilities from ordinal relationships between health states (HSs) to over-
come these issues, using the Analytic Hierarchy Process (AHP) approach. AHP is a 
multiple criteria decision analysis technique based upon pairwise comparisons, use-
ful for structuring complex prioritisation problems. It has been widely used in health 
settings. MethOds: The technique outlined was applied to the Measurement and 
Valuation of Health (MVH) study dataset. The number of occasions that each HS was 
preferred to each of the others was measured and represented by a 45*45 matrix. 
This was subsequently transformed into a scale indicating the significance of the 
difference between each pair of HSs. We describe 5 approaches to structure pairwise 
comparisons of HS preference (2 concave, 2 convex, 1 linear). A score for each HS was 
derived from this matrix’s principal eigenvector, and the matrix’s consistency cal-
culated. Results: All approaches predicted the rankings of HSs found in the MVH 
